Improving Molecular Testing and Personalized Medicine in Non-Small-Cell Lung Cancer in Ontario | Zendy

Chétana Lim | Zendy; Harman Sekhon | Zendy; Jean-Claude Cutz | Zendy; D. Hwang | Zendy; Suzanne KamelReid | Zendy; R.F. Carter | Zendy; Gilda da Cunha Santos | Zendy; Thomas K. Waddell | Zendy; Matthew Binnie | Zendy; Milan Patel | Zendy; Narinder Paul | Zendy; T. Chung | Zendy; Anthony Brade | Zendy; Robert H. El-Maraghi | Zendy; Christina Sit | Zendy; MingSound Tsao | Zendy; Natasha B. Leighl | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Improving Molecular Testing and Personalized Medicine in Non-Small-Cell Lung Cancer in Ontario

Author(s) -

Chétana Lim,

Harman Sekhon,

Jean-Claude Cutz,

D. Hwang,

Suzanne KamelReid,

R.F. Carter,

Gilda da Cunha Santos,

Thomas K. Waddell,

Matthew Binnie,

Milan Patel,

Narinder Paul,

T. Chung,

Anthony Brade,

Robert H. El-Maraghi,

Christina Sit,

MingSound Tsao,

Natasha B. Leighl

Publication year - 2017

Publication title -

current oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.053

H-Index - 51

eISSN - 1718-7729

pISSN - 1198-0052

DOI - 10.3747/co.24.3495

Subject(s) - medicine , lung cancer , context (archaeology) , medical physics , personalized medicine , cancer , specialty , pathology , intensive care medicine , bioinformatics , paleontology , biology

Although molecular testing has become standard in managing advanced nonsquamous non-small-cell lung cancer (nsclc), most patients undergo minimally invasive procedures, and the diagnostic tumour specimens available for testing are usually limited. A knowledge translation initiative to educate diagnostic specialists about sampling techniques and laboratory processes was undertaken to improve the uptake and application of molecular testing in advanced lung cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research